China will persevere with its "dynamic-clearing" approach to COVID-19 cases as soon as they emerge, health officials said on Saturday, adding that measures must be implemented more precisely and meet the needs of vulnerable people.
China reported 3,837 new COVID-19 infections on Nov. 4, of which 657 were symptomatic and 3,180 were asymptomatic, the National Health Commission said on Saturday.
New offshoots of the dominant BA.5 subvariant of Omicron known as BQ.1 and BQ.1.1 are gaining ground in the United States as the SARS-Cov-2 virus that triggered the COVID-19 pandemic continues to evolve.
The U.S. Supreme Court on Friday agreed to hear Amgen Inc's bid to revive patents on its cholesterol drug Repatha that were invalidated due to a legal challenge by rivals Regeneron Pharmaceuticals Inc and Sanofi SA .
BioNTech would initially import its COVID-19 vaccine into China if approvals are granted, said a spokesperson for the company on Friday, after German Chancellor Olaf Scholz said during a visit to Beijing that China would allow expatriates to receive the German company's vaccine.
The U.S. Centers for Disease Control and Prevention (CDC) on Friday estimated that Omicron subvariants BQ.1 and BQ.1.1 accounted for about 35% of coronavirus cases in the country in the week ending Nov.5 compared with 23.2% in the previous week.
The main psychoactive ingredient found in magic mushrooms can significantly reduce symptoms of difficult-to-treat depression, data from the largest clinical trial ever to test the keenly-watched compound has found.
An early fall spike in influenza cases has pushed U.S. hospitalization rates for the illness to the highest in a decade for this time of year, U.S. health officials said on Friday, noting that vaccination rates are down.
Swiss drugs regulator Swissmedic said on Friday that an analysis of bubbles that formed in vials of BionTech-Pfizer's COVID-19 booster shot revealed no indication of risk.
Boehringer Ingelheim and Eli Lilly said their diabetes drug Jardiance was shown to slow the progression of chronic kidney disease (CKD), as they seek to catch up with market segment leader AstraZeneca .
